Trends in Antibiotic Use in U.S. Hospitals during the COVID-19 Pandemic

  05 June 2021

We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. While total antibiotic use decreased between years, certain antibiotic use increased with higher COVID-19 burden.

Author(s): Ashley N Rose, MPH, James Baggs, PhD, Hannah Wolford, MSPH, Melinda M Neuhauser, PharmD, MPH, Arjun Srinivasan, MD, Adi V Gundlapalli, MD, PhD, Sujan Reddy, MD, MSc, Lyudmyla Kompaniyets, PhD, MS, Audrey F Pennington, PhD, MPH, Cheri Grigg, DVM, MPH, Sarah Kabbani, MD, MSc
Effective Surveillance  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!